Laboratoires Serono S.A.
Records under this name other than patents Laboratoires Serono S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Laboratoires Serono S.A.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,772,233 | Novel Arylamino N-Heteroaryl Compounds as Mek Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 7,879,888 | Thiazole derivatives and use thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,877,757 | Pyrazine derivatives and use as PI3K inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,043,254 | Medication delivery device Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,956,191 | 3-Arylamino Pyridine Derivatives Formerly held In force · High confidence | In force | High confidence | |
| US 9,447,055 | Alpha-Amino Esters of Hydroxypropylthiazolidine Carboxamide Derivative and Salt Form, Crystal Polymorph Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 7,713,947 | Cladribine Regimen for Treating Multiple Sclerosis Formerly held Term ended Term ended Oct 16, 2026 · High confidence | Term ended | Term ended Oct 16, 2026 | High confidence |
| US 8,133,699 | Minimal DNA sequence acting as a chromatin insulator and its use in protein expression Formerly held In force Term ended Oct 16, 2026 · From the USPTO record | In force | Term ended Oct 16, 2026 | From the USPTO record |
| US 7,951,359 | Compositions and Methods for Therapy or Prevention of Chemotherapy-Induced Neuropathy Formerly held Term ended Term ended Sep 28, 2026 · High confidence | Term ended | Term ended Sep 28, 2026 | High confidence |
| US 8,802,703 | Novel Arylamino N-Heteraryl Compounds as Mek Inhibitors Formerly held Lapsed on the fee record Ended Aug 12, 2026 · High confidence | Lapsed on the fee record | Ended Aug 12, 2026 | High confidence |